1. Home
  2. HAE vs NXE Comparison

HAE vs NXE Comparison

Compare HAE & NXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HAE
  • NXE
  • Stock Information
  • Founded
  • HAE 1971
  • NXE N/A
  • Country
  • HAE United States
  • NXE Canada
  • Employees
  • HAE N/A
  • NXE N/A
  • Industry
  • HAE Medical/Dental Instruments
  • NXE
  • Sector
  • HAE Health Care
  • NXE
  • Exchange
  • HAE Nasdaq
  • NXE Nasdaq
  • Market Cap
  • HAE 3.6B
  • NXE 4.1B
  • IPO Year
  • HAE 1991
  • NXE N/A
  • Fundamental
  • Price
  • HAE $62.98
  • NXE $5.59
  • Analyst Decision
  • HAE Strong Buy
  • NXE
  • Analyst Count
  • HAE 9
  • NXE 0
  • Target Price
  • HAE $103.56
  • NXE N/A
  • AVG Volume (30 Days)
  • HAE 1.4M
  • NXE 8.8M
  • Earning Date
  • HAE 02-06-2025
  • NXE 03-06-2025
  • Dividend Yield
  • HAE N/A
  • NXE N/A
  • EPS Growth
  • HAE 3.20
  • NXE N/A
  • EPS
  • HAE 2.54
  • NXE 0.20
  • Revenue
  • HAE $1,373,515,000.00
  • NXE N/A
  • Revenue This Year
  • HAE $7.56
  • NXE N/A
  • Revenue Next Year
  • HAE $3.13
  • NXE N/A
  • P/E Ratio
  • HAE $24.76
  • NXE $30.64
  • Revenue Growth
  • HAE 8.14
  • NXE N/A
  • 52 Week Low
  • HAE $58.80
  • NXE $4.95
  • 52 Week High
  • HAE $97.97
  • NXE $8.96
  • Technical
  • Relative Strength Index (RSI)
  • HAE 38.28
  • NXE 32.36
  • Support Level
  • HAE $58.80
  • NXE $5.82
  • Resistance Level
  • HAE $65.15
  • NXE $6.74
  • Average True Range (ATR)
  • HAE 2.76
  • NXE 0.28
  • MACD
  • HAE 0.34
  • NXE -0.06
  • Stochastic Oscillator
  • HAE 32.85
  • NXE 2.50

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

About NXE Nexgen Energy Ltd.

NexGen Energy Ltd is a mineral exploration company. It is engaged in the acquisition, exploration, evaluation and development of uranium properties in Canada. The company's projects portfolio consists of ROOK I, and the IsoEnergy, at the Athabasca Basin. The Rook I property hosts the world-class Arrow Zone, the Bow discovery. as well as the discovered Harpoon area located northeast of the Arrow deposit.

Share on Social Networks: